G04.3 Acute necrotizing hemorrhagic encephalopathy

Name of the Condition

• Acute necrotizing hemorrhagic encephalopathy

Summary

Acute necrotizing hemorrhagic encephalopathy is a rare, severe neurological condition characterized by rapid-onset brain inflammation with necrosis (tissue death) and hemorrhage (bleeding). It typically presents with acute neurological decline and requires urgent medical intervention. The condition is often associated with systemic infections or immune-mediated processes.

Causes

Acute necrotizing hemorrhagic encephalopathy is thought to result from an abnormal immune response, frequently triggered by viral infections (e.g., influenza, herpesviruses) or other systemic inflammatory conditions. The immune system’s overactivation leads to blood-brain barrier disruption, resulting in brain edema, hemorrhage, and tissue damage. In some cases, no clear infectious trigger is identified.

Risk Factors

• Recent viral or bacterial infections (e.g., influenza, streptococcal infections).
• Underlying autoimmune disorders.
• Immunosuppressive therapy or weakened immune system.
• Exposure to certain medications or toxins (rarely associated).

Symptoms

• Sudden onset of altered mental status, confusion, or coma.
• Seizures or convulsions.
• Headache, nausea, or vomiting.
• Focal neurological deficits (e.g., weakness, speech difficulties).
• Fever or signs of systemic infection.

Diagnosis

Diagnosis involves clinical evaluation, neurological examination, and imaging (e.g., MRI or CT) to identify characteristic brain lesions with necrosis and hemorrhage. Laboratory tests may assess for infectious or autoimmune markers. Cerebrospinal fluid analysis may show elevated pressure or inflammatory changes, though findings are often nonspecific.

Treatment Options

Treatment focuses on managing acute symptoms and underlying causes. Supportive care includes monitoring for increased intracranial pressure, seizure control, and addressing systemic infections or immune dysregulation. Corticosteroids or immunosuppressive therapies may be used in autoimmune cases, though evidence is limited.

Prognosis and Follow-Up

Prognosis is variable and often poor due to the condition’s severity. Survivors may experience long-term neurological deficits, including cognitive impairment, motor dysfunction, or seizures. Follow-up includes regular neurological assessments and rehabilitation to address residual symptoms.

Complications

• Permanent neurological damage (e.g., cognitive decline, paralysis).
• Recurrent seizures or epilepsy.
• Increased intracranial pressure leading to herniation.
• Multi-organ failure in severe cases.

Lifestyle & Prevention

Prevention is challenging due to the condition’s rarity and unclear triggers. General measures include prompt treatment of infections, maintaining immune health, and avoiding known triggers (e.g., certain medications) when possible. No specific lifestyle modifications are proven to reduce risk.

When to Seek Professional Help

Seek immediate medical attention for sudden neurological symptoms (e.g., confusion, seizures, severe headache) or signs of infection, especially after a recent illness. Early evaluation is critical to manage complications and improve outcomes.

Tips for Medical Coders

Document the clinical presentation, including acute neurological decline, imaging findings (necrosis/hemorrhage), and any identified triggers (e.g., infection, autoimmune history). Ensure specificity in coding by confirming the absence of other encephalitis subtypes (e.g., ADEM) to support accurate assignment of G04.3.